NDC 12496-0003-01 - OPVEE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 12496-0003
- Requested NDC
- 12496-0003-01
- Package NDCs from labels
- 12496-0003-1, 12496-0003-2, 12496-0003-01
- Manufacturer
- Indivior Inc.
- Effective date
- 2026-01-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OPVEE - Indivior Inc. | Indivior Inc. | 2026-01-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 12496-0003-1 | OPVEE | 100 uL in 1 VIAL, SINGLE-DOSE | SPRAY | 100 | 8 | |
| 12496-0003-1 | OPVEE | 1 in 1 BLISTER PACK | SPRAY | 1 | 8 | |
| 12496-0003-2 | OPVEE | 2 in 1 CARTON | SPRAY | 2 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 12496-0003 | OPVEE (NALMEFENE HYDROCHLORIDE) SPRAY [INDIVIOR INC.] | 6 | Current NDC, 3 package rows | 20241114_999a4269-9e54-4801-b2ac-2a7276f0b94f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 12496-0003-1 | EA - Each | 12496-0003 | 6a027088-a101-4715-8c9a-8381a64f5773 | 1 | 2023-09-05 |
| 12496-0003-2 | EA - Each | 12496-0003 | 752659b3-3b15-4045-9c62-912e31276bfe | 1 | 2023-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zurnai | NALMEFENE HYDROCHLORIDE | Knoa Pharma LLC | a59a5847-9fe4-4341-a203-be0a5e6d3e36 | 2026-07-31 | Warnings, Adverse reactions | K7K69QC05X |
| NALMEFENE HYDROCHLORIDE | NALMEFENE HYDROCHLORIDE | Knoa Pharma LLC | 3abfbffc-9e52-4fc6-ae92-6e0a97f4afe7 | 2026-05-01 | Warnings, Adverse reactions | K7K69QC05X |
| OPVEE | NALMEFENE HYDROCHLORIDE | Indivior Inc. | 999a4269-9e54-4801-b2ac-2a7276f0b94f | 2026-01-08 | Warnings, Adverse reactions | NDA217470 12496-0003-1 12496-0003-2 12496-0003 12496000301 2639727 2639721 47e34536-62c2-9ceb-e063-6294a90a57be 999a4269-9e54-4801-b2ac-2a7276f0b94f K7K69QC05X |
| nalmefene hydrochloride | NALMEFENE HYDROCHLORIDE INJECTION | Chengdu Shuode Pharmaceutical Co., Ltd | 22d67228-6c24-47ca-afc7-52ef279520a0 | 2023-12-08 | Warnings, Adverse reactions | K7K69QC05X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.